Medical Devices

63 tickers in this theme
NewestHighest Score Ranks all matching reports in this category by score, highest first.
The Cooper Companies, Inc.
COO·Healthcare
B ★★★Hold
Current$54.14
Target$63.36
Return+17.0%
Sep 15, 2026

CooperCompanies offers a discounted entry into durable contact-lens and fertility franchises with strong cash flow and buybacks, but it must normalize U.S. channels and rebuild credibility after the Q3 guidance reset and failed CooperSurgical sale.

Score
70
MiniMed Group, Inc.
MMED·Healthcare
F Avoid
Current$22.50
Sep 14, 2026

MiniMed has a credible diabetes-technology growth engine led by Flex, CGM attachment and a strong pipeline, but negative free cash flow, low current returns and an expensive forward multiple make the post-spin risk-reward unattractive today.

Score
44
Agilent Technologies, Inc.
A·Healthcare
B ★★★Hold
Current$157.93
Target$172.64
Return+9.3%
Aug 29, 2026

Agilent is a high-quality, cash-generative tollbooth in life sciences and analytical instruments with rapid margin expansion, though investors must accept a steep valuation premium amid cyclical biotech capex headwinds and China trade risk.

Score
84